NCCN GUIDELINES AND NCCN COMPENDIUM UPDATED
NCCN Flash Update sent May 27, 2014
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Pancreatic Adenocarcinoma. These NCCN Guidelines® are currently available as Version 2.2014.
- For clarification, “nab-paclitaxel” has been changed to “albumin-bound paclitaxel” throughout the guidelines.
- The Discussion section has been updated to reflect the changes in the algorithm. (MS-1)
*For your reference, the previous update (Version 1.2014) to the NCCN Guidelines for Pancreatic Adenocarcinoma, distributed on January 6, 2014, is available at the following link: http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf#Page=4
For the complete updated versions of the NCCN Guidelines, the NCCN Drug & Biologics Compendium (NCCN Compendium®), and the NCCN Chemotherapy Order Templates (NCCN Templates®), please visit NCCN.org.
To access the NCCN Biomarkers Compendium®, please visit NCCN.org/biomarkers.
To view the NCCN Guidelines for Patients®, please visit NCCN.org/patients.
Free NCCN Guidelines apps iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps